v3.25.2
Accrued Expenses and Other Current Liabilities
6 Months Ended 12 Months Ended
Jun. 30, 2025
Dec. 31, 2024
IKENA ONCOLOGY INC    
Accrued Expenses and Other Current Liabilities
5. Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consisted of the following (in thousands):
 
    
June 30, 2025
    
December 31, 2024
 
Employee compensation
   $ 483      $ 1,730  
Research and development expenses
     1,108        1,935  
Professional fees
     1,348        2,409  
Other
     39        23  
  
 
 
    
 
 
 
Total
   $ 2,978      $ 6,097  
  
 
 
    
 
 
 
6. ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
Accrued expenses and other current liabilities consist of the following (in thousands):
 
    
December 31,
 
    
2024
    
2023
 
Employee compensation
   $ 1,730      $ 3,311  
Research and development expenses
     1,935        3,964  
Professional fees
     2,409        1,221  
Other
     23        85  
  
 
 
    
 
 
 
Total
   $ 6,097      $ 8,581